Since cytokine release syndrome with elevation of interleukin‐6 (IL‐6) is considered to be
associated with severe cases of coronavirus disease 2019 (COVID‐19); IL‐6 inhibitors, such …

The clinical presentation of COVID-19 is very heterogeneous, ranging from asymptomatic to
severe, which could lead to the need for mechanical ventilation or even death. We analyzed …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
alsoknownasthe2019novelCoronavirus (2019-nCoV), has caused a recent outbreak of …

IL-6 is one of the major mediators of the hyper-inflammatory responses with complex
biological functions as it can signal via different modes of action. IL-6 by classical signalling …

The prognostic value of interleukin-6 in COVID-19 needs to be clarified. In this retrospective
study, COVID-19 patients treated in Renmin Hospital of Wuhan University from Jan 7 to Feb …

The original version of this article unfortunately contained mistakes. There is an incorrect
unit of IL-6 in Fig. 1 and Supplementary Table 1. It should be pg/mL rather than ng/mL. The …

Background. SARS‐CoV‐2 is responsible for COVID‐19, a clinically heterogeneous
disease, ranging from being completely asymptomatic to life‐threating manifestations. An …

Several studies have revealed that the hyper-inflammatory response induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease …

The pandemic Coronavirus-disease 19 (COVID-19) is characterized by a heterogeneous
clinical course. While most patients experience only mild symptoms, a relevant proportion …

Abstract Background Coronavirus disease 2019 (COVID-19) was announced in early
December 2019. The pandemic situation is declared. This study aimed to evaluate the role …